COVID 19: Where Are We Heading?
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Epidemics and Pandemics in Victoria: Historical Perspectives
Epidemics and pandemics in Victoria: Historical perspectives Research Paper No. 1, May 2020 Ben Huf & Holly Mclean Research & Inquiries Unit Parliamentary Library & Information Service Department of Parliamentary Services Parliament of Victoria Acknowledgments The authors would like to thank Annie Wright, Caley Otter, Debra Reeves, Michael Mamouney, Terry Aquino and Sandra Beks for their help in the preparation of this paper. Cover image: Hospital Beds in Great Hall During Influenza Pandemic, Melbourne Exhibition Building, Carlton, Victoria, circa 1919, unknown photographer; Source: Museums Victoria. ISSN 2204-4752 (Print) 2204-4760 (Online) Research Paper: No. 1, May 2020 © 2020 Parliamentary Library & Information Service, Parliament of Victoria Research Papers produced by the Parliamentary Library & Information Service, Department of Parliamentary Services, Parliament of Victoria are released under a Creative Commons 3.0 Attribution-NonCommercial- NoDerivs licence. By using this Creative Commons licence, you are free to share - to copy, distribute and transmit the work under the following conditions: . Attribution - You must attribute the work in the manner specified by the author or licensor (but not in any way that suggests that they endorse you or your use of the work). Non-Commercial - You may not use this work for commercial purposes without our permission. No Derivative Works - You may not alter, transform, or build upon this work without our permission. The Creative Commons licence only applies to publications produced by the -
Novel H1N1 Influenza Updated Key Points June 11, 2009 • On
Novel H1N1 Influenza Updated Key Points June 11, 2009 • On June 11, 2009, the World Health Organization (WHO) raised the worldwide pandemic alert level to Phase 6. • Designation of this phase indicates that a global pandemic is underway. • There are now community level outbreaks ongoing in other parts of the world. • State and international borders don’t matter at this point. The bottom line is that this new virus is among us all. • While U.S. influenza surveillance systems indicate that overall flu activity is decreasing in the United States, novel H1N1 outbreaks are ongoing in different parts of the U.S., in some cases with intense activity. • In the United States, this virus has been spreading efficiently from person-to-person since April and, as we have been saying for some time, we do expect that we will see more cases, more hospitalizations and more deaths from this virus. • Because there is already widespread novel H1N1 disease in the United States, the WHO Phase 6 declaration does not change what the United States is currently doing to keep people healthy and protected from the virus. • Thus there is no change to CDC’s recommendations for individuals and communities. • WHO’s decision to raise the pandemic alert level to Phase 6 is a reflection of epidemiological changes in other parts of the world and not a reflection of any change in the novel H1N1 virus or associated illness. • At this time, most of the people who have become ill with novel H1N1 in the United States have not become seriously ill and have recovered without hospitalization. -
Swine Influenza a (H1N1 Virus): a Pandemic Disease
Review Article Swine Influenza A (H1N1 Virus): A Pandemic Disease Gangurde HH, Gulecha VS, Borkar VS, Mahajan MS, Khandare RA, Mundada AS Department of Pharmaceutics, SNJB’s SSDJ College of Pharmacy, Neminagar, Chandwad, Nasik, Maharashtra, India ARTICLE INFO ABSTRACT Article history: Swine influenza (SI) is a respiratory disease of pigs caused by type A influenza that regularly Received 9 September 2009 causes pandemics. SI viruses do not normally infect humans; however, human infections with Accepted 18 September 2009 SI do occur, and cases of human-to-human spread of swine flu viruses have been documented. Available online 19 October 2011 Swine influenza also called as swine flu, hog flu, and pig flu that refers to influenza is caused by Keywords: those strains of influenza virus, called SI virus (SIV), that usually infect pigs endemically. As of Coughing 2009, these strains are all found in influenza C virus and subtypes of influenza A virus known as Fever H1N1, H1N2, H3N1, H3N2, and H2N3. The viruses are 80–120 nm in diameter. The transmission of H1N1 SIV from pigs to humans is not common and does not always cause human influenza, often only sore throat resulting in the production of antibodies in the blood. The meat of the animal poses no risk of swine flu swine influenza virus transmitting the virus when properly cooked. If the transmission does cause human influenza, it is called zoonotic swine flu. People who work with pigs, especially people with intense exposures, are at an increased risk of catching swine flu. In the mid-20th century, the identification of influenza subtypes became possible; this allowed accurate diagnosis of transmission to humans. -
A Review on Swine Flu Infection and Strategies for Its Treatment in Future
Journal of Analytical & Pharmaceutical Research Review Article Open Access A review on swine flu infection and strategies for its treatment in future Abstract Volume 9 Issue 1 - 2020 H1N1 influenza infection is one of the most influential types of influenza viruses that enamored and surrenders almost all age gatherings of human populaces. This paper exhibits Prashant Kumar Dhakad, Mahaveer Singh School of Pharmaceutical Sciences, Jaipur National University, nitty-gritty data in regards to general mechanism of H1N1 infection, the impact of swine flu in people, correlation of swine flu infection with liquor utilization, common cold, and India noteworthiness of obesity. Pandemic spread in 2009, the pharmacological role of plant Correspondence: Prashant Kumar Dhakad PhD, Assistant supplements in context of H N and their uses and a metric study showing the ranking 1 1 Professor, School of Pharmaceutical Sciences, Jaipur National of supplements with the highest frequency of occurrence (F supplement) and ranking of University, Jagatpura, Jaipur, Rajasthan-302017, India, supplement with highest probabilities of co-occurrence with H1N1 (P supplement) has been Email portrayed in the present review. Received: November 22, 2019 | Published: January 24, 2020 Keywords: H1N1, influenza virus, swine flu, pandemic, f supplement, p supplement Introduction glycoprotein on the outside of upper respiratory tract or erythrocytes of host and chemical NA cuts sialic corrosive from cell surface and The present survey deals with information regarding the sufferings free relatives of infection from tainted patient cells. Swine influenza caused during the H1N1 infection happened in 2009, pathophysiology taints the respiratory tract of pigs, bringing about nasal discharges, a of swine influenza disease, genomic impact of swine influenza in yelping hack, diminished hunger, and drowsy conduct. -
Policy 11-2-2 Communicable Disease Plan
WNC Policies and Procedures Manual Procedure: COMMUNICABLE DISEASE PLAN (Re: 9/3/2009) Policy No.: 11-2-2 Department: Environmental Health and Safety (EH&S) Contact: Environmental Health and Safety Coordinator Policy: This plan addresses communicable disease outbreaks and defines the steps that WNC will take in preparation for, and how the college will respond to a health related emergency, epidemic or pandemic. This document is consistent with other WNC emergency planning documents. This plan cites several different communicable diseases and is intended for use in all communicable disease emergencies. The severity of communicable diseases can vary greatly. Much of this plan is based on influenza that may be greater in severity than the H1N1 virus. The intent of this plan is to protect lives and effectively use available resources to maintain an appropriate level of college operations during instances of communicable disease emergencies. Table of Contents Sections: Page 1. Introduction 2 2. References 3 3. Responsibilities 4 4. Preparedness 6 5. Confirmation of a Communicable Disease Emergency 8 6. Confirmation of Pandemic Infectious 12 7. Public Relations and Communication 14 8. Return to Service 14 9. Division/Department/Campus/Unit Communicable Disease Continuity Plans 14 10. Return to Service/Recovery 15 Appendix A: University Nevada Reno Pandemic 16 Influenza Plan Introduction Appendix B: WNC’s Template for Division, Department, 20 Campus, Unit Communicable Disease Continuity of Operation Plan Appendix C: WNC Communicable Disease Response Plan 28 Appendix D: Acknowledgement 34 1 Definitions: Antiviral Drugs: A class of medication used specifically for treating viral infections. Like antibiotics, specific antiviral are used for specific viruses. -
Community Mitigation Guidelines to Prevent Pandemic Influenza – United States, 2017 Technical Report 1: Chapters 1-4 the Boxes
Community Mitigation Guidelines to Prevent Pandemic Influenza – United States, 2017 Technical Report 1: Chapters 1-4 The boxes, figures, and tables referred to in these chapters are in the affiliated MMWR RR report. The appendices referred to in this document can be found in Technical Report 2. Table of Contents Chapters Content Page Numbers Chapters/Sections Chapter 1 Introduction and NPI Overview 3-12 Introduction 3 o NPIs: Our Earliest Line of Defense o Updating the 2007 Community Mitigation Strategy NPI Overview 4 o NPI Goals and Rationale o NPI Pre-pandemic Planning Issues o Community Engagement and Preparedness References 11 Chapter 2 New Tools for Assessment, Planning, and Guidelines 13-18 Development Novel Influenza Virus Pandemic Intervals 13 Influenza Risk Assessment Tool (IRAT) for Influenza A 13 Viruses Circulating in Animals Pandemic Severity Assessment Framework (PSAF) 14 o Assessing Pandemic Severity and Health Impact o Guiding Development of NPI Recommendations When a Pandemic Begins Pre-pandemic Planning Scenarios to Guide NPI 15 Implementation WHO Guidance on Pandemic Phases, Severity Assessments, 16 and NPI Implementation References 17 Chapter 3 NPI Toolbox: Evidence Base, Implementation Issues, and 19-45 Research Gaps Personal NPIs 19 o Personal Protective Measures for Everyday Use: Voluntary Home Isolation, Respiratory Etiquette, and Hand Hygiene o Personal Protective Measures Reserved for Pandemics: Voluntary Home Quarantine and Use of Face Masks in Community Settings Community NPIs 25 o School Closures -
Responding to an Influenza Pandemic
Table of Contents Summary of Recommendations Chapter 1 Introduction Chapter 2 Phases of a pandemic: WHO, EU and Irish Chapter 3 Epidemiology and potential impact Chapter 4 Surveillance, detection and situation monitoring Chapter 5 Public health response: Antivirals Chapter 6 Public health response: Vaccines Chapter 7 Public health response: Non-pharmaceutical interventions in the Pandemic Alert Period (WHO phases 3, 4 and 5) Chapter 8 Public health response: Non-pharmaceutical interventions during the Pandemic (phase 6) Chapter 9 Health system response: Clinical management of patients with influenza like illness during an influenza pandemic Chapter 10 Health system response: Infection control Chapter 11 Influenza in animals and human health implications Supplements Supplement 3 Modelling and potential impact Supplement 10 Guidance for pandemic influenza: Infection control in hospitals, community and primary care settings Supplement 11 Guidance on the public health management of avian influenza Part 1 Guidance on public health actions to be taken on notification of avian influenza in birds in Ireland Part 2 Irish guidelines for the public health management of human cases of influenza (A/H5N1) and their contacts Glossary Executive summary 1. Introduction a. This revised guidance, prepared in November 2008, replaces the draft version for consultation published in January 2007, and all other documents previously published by the Pandemic Influenza Expert Group (PIEG). b. The aim of the document is to provide timely, authoritive information on pandemic influenza, to provide clinical guidance for health professionals, and to provide public health advice for the public, public health professionals, and policy makers in the Department of Health and Children and other government Departments and agencies, all of whom will be involved in the response to an influenza pandemic. -
Interim Pre-Pandemic Planning Guidance: Community
Interim Pre-pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in the United States— Early, Targeted, Layered Use of Nonpharmaceutical Interventions NT O E F D M E T F R E A N P S E E D U N A I IC TE R D S ME TATES OF A OF TRAN NT SP E O M R T T R A A T P I O E N D U N A I C T I E R D E M ST A ATES OF Page 2 was blank in the printed version and has been omitted for web purposes. Page 2 was blank in the printed version and has been omitted for web purposes. Interim Pre-Pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in the United States— Early, Targeted, Layered Use of Nonpharmaceutical Interventions February 2007 Page 4 was blank in the printed version and has been omitted for web purposes. Page 4 was blank in the printed version and has been omitted for web purposes. Contents I Executive Summary ........................................................................ 07 II Introduction .................................................................................. 17 III Rationale for Proposed Nonpharmaceutical Interventions .......................... 23 IV Pre-pandemic Planning: the Pandemic Severity Index ............................. 31 V Use of Nonpharmaceutical Interventions by Severity Category ................... 35 VI Triggers for Initiating Use of Nonpharmaceutical Interventions ................... 41 VII Duration of Implementation of Nonpharmaceutical Interventions.......................... 45 VIII Critical Issues for the Use of Nonpharmaceutical Interventions ................... 47 IX Assessment of the Public on Feasibility of Implementation and Adherence ..... 49 X Planning to Minimize Consequences of Community Mitigation Strategy ....... 51 XI Testing and Exercising Community Mitigation Interventions .................... -
Twitter Influence on UK Vaccination and Antiviral Uptake During the 2009 H1N1 Pandemic
Twitter influence on UK vaccination and antiviral uptake during the 2009 H1N1 pandemic Article (Published Version) McNeill, Andrew, Harris, Peter and Briggs, Pam (2016) Twitter influence on UK vaccination and antiviral uptake during the 2009 H1N1 pandemic. Frontiers in Public Health, 4. ISSN 2296-2565 This version is available from Sussex Research Online: http://sro.sussex.ac.uk/id/eprint/61335/ This document is made available in accordance with publisher policies and may differ from the published version or from the version of record. If you wish to cite this item you are advised to consult the publisher’s version. Please see the URL above for details on accessing the published version. Copyright and reuse: Sussex Research Online is a digital repository of the research output of the University. Copyright and all moral rights to the version of the paper presented here belong to the individual author(s) and/or other copyright owners. To the extent reasonable and practicable, the material made available in SRO has been checked for eligibility before being made available. Copies of full text items generally can be reproduced, displayed or performed and given to third parties in any format or medium for personal research or study, educational, or not-for-profit purposes without prior permission or charge, provided that the authors, title and full bibliographic details are credited, a hyperlink and/or URL is given for the original metadata page and the content is not changed in any way. http://sro.sussex.ac.uk ORIGINAL RESEARCH published: 22 February 2016 doi: 10.3389/fpubh.2016.00026 Twitter influence on UK Vaccination and Antiviral Uptake during the 2009 H1N1 Pandemic Andrew McNeill1 , Peter R. -
Disparities in the 2009 Swine Flu Pandemic and COVID-19: a Literature Review
University of Central Florida STARS Honors Undergraduate Theses UCF Theses and Dissertations 2021 Disparities in the 2009 Swine Flu Pandemic and COVID-19: A Literature Review Yusuf Amawi University of Central Florida Part of the Health and Medical Administration Commons, and the Virus Diseases Commons Find similar works at: https://stars.library.ucf.edu/honorstheses University of Central Florida Libraries http://library.ucf.edu This Open Access is brought to you for free and open access by the UCF Theses and Dissertations at STARS. It has been accepted for inclusion in Honors Undergraduate Theses by an authorized administrator of STARS. For more information, please contact [email protected]. Recommended Citation Amawi, Yusuf, "Disparities in the 2009 Swine Flu Pandemic and COVID-19: A Literature Review" (2021). Honors Undergraduate Theses. 895. https://stars.library.ucf.edu/honorstheses/895 DISPARITIES IN THE 2009 SWINE FLU PANDEMIC AND COVID-19: A LITERATURE REVIEW by YUSUF A. AMAWI A thesis submitted in partial fulfillment of the requirements for the Honors in the Major Program in Health Services Administration in the Department of Health Management and Informatics in the College of Community Innovation and Education and in the Burnett Honors College at the University of Central Florida Orlando, Florida Spring Term 2021 Thesis Chair: Yara M. Asi, Ph.D. I © 2021 Yusuf A. Amawi II Abstract The purpose of this thesis was to identify causes of disparities in affliction (infection) and mortality for minority populations (Blacks, Hispanics, Asians, and American Indian/Alaskan Natives) during the Swine Flu (H1N1) and COVID-19 (Sars-Cov-2) Pandemics. -
Influenza Pandemic, 1957
TM Real-Life Public Health According to Sir Mick “No, you can't always get what you want You can't alwayygs get what you want You can't always get what you want… TM …And if yyyou try sometime you find You get what you need….” Well, not always…Sometimes you don’t ggypet what you expect or what you want or what you need! TM The H1N1 Response in the United States Surprise, Uncertainty and Too Little Information Peter Houck, MD CDC Division of Global Migration and Quarantine Mexico City, June 2009 TM Outline • What we expppected for a pandemic • How we had planned to respond • What we actually saw and did • What we are planning TM What Did We Expect? TM Previous Influenza A Pandemics • 1918-19, "Spanish flu" (H1N1) • 20-50M died world-wide (~500K in U.S.) • ~50% of deaths in young, healthy adults • Hemorrhagic pneumonia • 1957-58, "Asian flu" (H2N2) • ~70,000 attributable deaths in U.S. • 1968-69, "Hong Kong flu" (H3N2) • 34K excess U.S. deaths TM Pandemic Severity Index 1918 1957, 1968 TM Influenza Pandemic, 1957 TM TM Pandemic Intervals Inter- Pandemic Pandemic Alert Period Pandemic Period WHO Period Phase 1 2 3 4 5 6 New Domestic Suspected Confirmed First Widespread Animal Human Human Human Outbreaks Spread Throughout United States Recovery Outbreak in At- Outbreak Outbreak Case in Overseas USG Risk Country Overseas Overseas N.A. Stage 0 1 2 3 4 5 6 “Mitigate” “Contain” “Quench” CDC Investigation Recognition Initiation Accel Peak Decel Resolution Interval TM Most likely candidate for next pandemic influenza? Was thought to be influenza A H5N1 TM How Did We Plan to Respond? TM Layered Defense Against a Pandemic • Quarantine and isolation • Health screening at ports of entry • Distribution of inbound flights • En route screening • Health screening at ports of embarkation • Possible travel restrictions from affected regions • Containment at source: travel restrictions, antivirals, quarantine, and isolation (World Health Origin of Organization Rapid Reaction) Pandemic TM Screening at Entry TM David Fitzsimmons, Arizona Daily Star, 4/22/03 U.S. -
A Comprehensive Laboratory Animal Facility Pandemic Response Plan
Journal of the American Association for Laboratory Animal Science Vol 49, No 5 Copyright 2010 September 2010 by the American Association for Laboratory Animal Science Pages 623–632 A Comprehensive Laboratory Animal Facility Pandemic Response Plan Gordon S Roble,1,2,* Naomi M Lingenhol,3 Bryan Baker,3 Amy Wilkerson,4 and Ravi J Tolwani1,3 The potential of a severe influenza pandemic necessitates the development of an organized, rational plan for continued laboratory animal facility operation without compromise of the welfare of animals. A comprehensive laboratory animal program pandemic response plan was integrated into a university-wide plan. Preparation involved input from all levels of organizational hierarchy including the IACUC. Many contingencies and operational scenarios were considered based on the severity and duration of the influenza pandemic. Trigger points for systematic action steps were based on the World Health Organization’s phase alert criteria. One extreme scenario requires hibernation of research operations and maintenance of reduced numbers of laboratory animal colonies for a period of up to 6 mo. This plan includes active recruitment and cross- training of volunteers for essential personnel positions, protective measures for employee and family health, logistical arrangements for delivery and storage of food and bedding, the removal of waste, and the potential for euthanasia. Strate- gies such as encouraging and subsidizing cryopreservation of unique strains were undertaken to protect valuable research assets and intellectual property. Elements of this plan were put into practice after escalation of the pandemic alerts due to influenza A (H1N1) in April 2009. Abbreviations: RUCBC, The Rockefeller University Comparative Bioscience Center; WHO, World Health Organization.